相关实验视频
Updated: Jul 17, 2026

08:56
Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
11.3K
孤儿GPR52作为一个新兴的神经治疗点
Saghir Ali1, Pingyuan Wang1, Ryan E Murphy1
1Chemical Biology Program, Department of Pharmacology and Toxicology, and Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX 77555, USA.
Drug discovery today
|February 22, 2024
概括
G蛋白结合受体52 (GPR52) 在神经疾病中起作用. 准GPR52为精神分裂症和亨廷顿病等疾病提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- G蛋白结合受体52 (GPR52) 是一个保存的,大脑丰富的受体.
- 它与Gs/olf蛋白结合,影响循环AMP (cAMP) 信号传递.
- GPR52与各种生理和病理的大脑过程有关.
研究的目的:
- 审查关于GPR52受体分布,结构和功能的当前知识.
- 为了突出发现小分子GPR52连接体的最新进展.
- 讨论针对GPR52的治疗潜力和挑战.
主要方法:
- 关于GPR52研究的文献综述.
- 对GPR52配体的药物发现工作的分析.
- 对针对GPR52的药物的临床试验进展的讨论.
主要成果:
- 调节GPR52活动可能治疗精神分裂症和亨廷顿病.
- 一种口服可用的GPR52激动剂 (HTL0048149) 正在精神分裂症的I期临床试验中.
- 在识别小分子GPR52配体方面取得了重大进展.
结论:
- GPR52是神经和精神疾病的有前途的治疗点.
- 需要进一步的研究和药物开发,以克服针对GPR52.2的挑战.
- 准GPR52有可能成为人类神经疾病的新疗法.
相关概念视频
G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

